Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
once daily FLAP inhibitor (5-lipoxygenase-activating protein inhibitor)
reaching a maximum in the 3 mg/kg/day dose group of 70% above vehicle in the initial efflux rate
HO-1 expression and protects rat brains against focal ischemia
ClH/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19
67% in Miapaca-2 cells and from 29
Orexin 2 Receptor Agonist Size:Contact [email protected] for quotation once daily FLAP inhibitor (5-lipoxygenase-activatingOrexin 2 Receptor Agonist is a potent (EC50 on OX2R is 23 nM) and OX2R selective (OX1R OX2R EC50 ratio is 70) agonist. IC50 value: 23 nM (EC50)Target: Orexin 2 ReceptorOrexin 2 Receptor Agonist shows not only potentactivity but also high selectivity for OX2R over OX1R. In CHO cells overexpressing hOX1R and HEK 293 cells overexpressing hOX2R, compound 26 displaced [125I]orexin A in a concentration dependent manner: 26 bound to hOX2R and hOX1R with Ki
US$ 850.00
US$ 134.00
US$ 113.50
US$ 130.00
US$ 130.00
US$ 700.00
US$ 1150.00
US$ 350.00